Cargando…
Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue
AIMS: Liraglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist used as an anti-hyperglycemic agent in type 2 diabetes treatment and recently approved for obesity management. Weight loss is attributed to appetite suppression, but therapy may also increase energy expenditure. To f...
Autores principales: | Oliveira, Fernanda C. B., Bauer, Eduarda J., Ribeiro, Carolina M., Pereira, Sidney A., Beserra, Bruna T. S., Wajner, Simone M., Maia, Ana L., Neves, Francisco A. R., Coelho, Michella S., Amato, Angelica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771968/ https://www.ncbi.nlm.nih.gov/pubmed/35069450 http://dx.doi.org/10.3389/fendo.2021.803363 |
Ejemplares similares
-
SAT-552 Oxidative Stress Induces Type 3 Deiodinase on Multiple Tissues in Disease: Implications to Nonthyroidal Illness Syndrome Pathophysiology
por: Wajner, Simone, et al.
Publicado: (2019) -
GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice
por: Coelho, Michella S., et al.
Publicado: (2016) -
Systemic β-Adrenergic Stimulation of Thermogenesis Is Not Accompanied by Brown Adipose Tissue Activity in Humans
por: Vosselman, Maarten J., et al.
Publicado: (2012) -
Sodium selenite supplementation does not fully restore oxidative stress-induced deiodinase dysfunction: Implications for the nonthyroidal illness syndrome
por: Wajner, Simone Magagnin, et al.
Publicado: (2015) -
Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Marschner, Rafael Aguiar, et al.
Publicado: (2023)